BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 23167414)

  • 21. Reduction of coactivator expression by antisense oligodeoxynucleotides inhibits ERalpha transcriptional activity and MCF-7 proliferation.
    Cavarretta IT; Mukopadhyay R; Lonard DM; Cowsert LM; Bennett CF; O'Malley BW; Smith CL
    Mol Endocrinol; 2002 Feb; 16(2):253-70. PubMed ID: 11818499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation.
    Schlange T; Matsuda Y; Lienhard S; Huber A; Hynes NE
    Breast Cancer Res; 2007; 9(5):R63. PubMed ID: 17897439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Src Is a Potential Therapeutic Target in Endocrine-Resistant Breast Cancer Exhibiting Low Estrogen Receptor-Mediated Transactivation.
    Guest SK; Ribas R; Pancholi S; Nikitorowicz-Buniak J; Simigdala N; Dowsett M; Johnston SR; Martin LA
    PLoS One; 2016; 11(6):e0157397. PubMed ID: 27308830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced antiangiogenic therapy of squamous cell carcinoma by combined endostatin and epidermal growth factor receptor-antisense therapy.
    Li M; Ye C; Feng C; Riedel F; Liu X; Zeng Q; Grandis JR
    Clin Cancer Res; 2002 Nov; 8(11):3570-8. PubMed ID: 12429648
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bradykinin-induced p42/p44 MAPK phosphorylation and cell proliferation via Src, EGF receptors, and PI3-K/Akt in vascular smooth muscle cells.
    Yang CM; Lin MI; Hsieh HL; Sun CC; Ma YH; Hsiao LD
    J Cell Physiol; 2005 Jun; 203(3):538-46. PubMed ID: 15573401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of human colon cancer cell growth by antisense oligodeoxynucleotides targeted at basic fibroblast growth factor.
    Netzer P; Domek M; Pai R; Halter F; Tarnawski A
    Aliment Pharmacol Ther; 2001 Oct; 15(10):1673-9. PubMed ID: 11564009
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protein-tyrosine-phosphatase-mediated epidermal growth factor (EGF) receptor transinactivation and EGF receptor-independent stimulation of mitogen-activated protein kinase by bradykinin in A431 cells.
    Graness A; Hanke S; Boehmer FD; Presek P; Liebmann C
    Biochem J; 2000 Apr; 347(Pt 2):441-7. PubMed ID: 10749673
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiproliferative effect of c-myc antisense phosphorothioate oligodeoxynucleotides in malignant glioma cells.
    Broaddus WC; Chen ZJ; Prabhu SS; Loudon WG; Gillies GT; Phillips LL; Fillmore H
    Neurosurgery; 1997 Oct; 41(4):908-15. PubMed ID: 9316053
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The proto-oncogene c-Src and its downstream signaling pathways are inhibited by the metastasis suppressor, NDRG1.
    Liu W; Yue F; Zheng M; Merlot A; Bae DH; Huang M; Lane D; Jansson P; Lui GY; Richardson V; Sahni S; Kalinowski D; Kovacevic Z; Richardson DR
    Oncotarget; 2015 Apr; 6(11):8851-74. PubMed ID: 25860930
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Delivery of antisense oligodeoxyribonucleotides against the human epidermal growth factor receptor into cultured KB cells with liposomes conjugated to folate via polyethylene glycol.
    Wang S; Lee RJ; Cauchon G; Gorenstein DG; Low PS
    Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3318-22. PubMed ID: 7724560
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SRC family kinases mediate epidermal growth factor receptor ligand cleavage, proliferation, and invasion of head and neck cancer cells.
    Zhang Q; Thomas SM; Xi S; Smithgall TE; Siegfried JM; Kamens J; Gooding WE; Grandis JR
    Cancer Res; 2004 Sep; 64(17):6166-73. PubMed ID: 15342401
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gastrin-releasing peptide promotes the growth of HepG2 cells via EGFR-independent ERK1/2 activation.
    Li X; Lv Y; Yuan A; Yi S; Ma Y; Li Z
    Oncol Rep; 2010 Aug; 24(2):441-8. PubMed ID: 20596631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antisense epidermal growth factor receptor RNA transfection in human malignant glioma cells leads to inhibition of proliferation and induction of differentiation.
    Tian XX; Lam PY; Chen J; Pang JC; To SS; Di-Tomaso E; Ng HK
    Neuropathol Appl Neurobiol; 1998 Oct; 24(5):389-96. PubMed ID: 9821170
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Downregulation of microRNA-4295 enhances cisplatin-induced gastric cancer cell apoptosis through the EGFR/PI3K/Akt signaling pathway by targeting LRIG1.
    Yan R; Li K; Yuan DW; Wang HN; Zhang Y; Dang CX; Zhu K
    Int J Oncol; 2018 Dec; 53(6):2566-2578. PubMed ID: 30320337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antisense oligonucleotides targeting the epidermal growth factor receptor inhibit proliferation, induce apoptosis, and cooperate with cytotoxic drugs in human cancer cell lines.
    Ciardiello F; Caputo R; Troiani T; Borriello G; Kandimalla ER; Agrawal S; Mendelsohn J; Bianco AR; Tortora G
    Int J Cancer; 2001 Jul; 93(2):172-8. PubMed ID: 11410862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potentiation of epidermal growth factor-mediated oncogenic transformation by sialidase NEU3 leading to Src activation.
    Yamamoto K; Takahashi K; Shiozaki K; Yamaguchi K; Moriya S; Hosono M; Shima H; Miyagi T
    PLoS One; 2015; 10(3):e0120578. PubMed ID: 25803810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Central role of p53 on regulation of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) expression in mammary carcinoma.
    Pal S; Datta K; Mukhopadhyay D
    Cancer Res; 2001 Sep; 61(18):6952-7. PubMed ID: 11559575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell-surface perturbations of the epidermal growth factor and vascular endothelial growth factor receptors by phosphorothioate oligodeoxynucleotides.
    Rockwell P; O'Connor WJ; King K; Goldstein NI; Zhang LM; Stein CA
    Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6523-8. PubMed ID: 9177251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dasatinib, a multi-kinase inhibitor increased radiation sensitivity by interfering with nuclear localization of epidermal growth factor receptor and by blocking DNA repair pathways.
    Raju U; Riesterer O; Wang ZQ; Molkentine DP; Molkentine JM; Johnson FM; Glisson B; Milas L; Ang KK
    Radiother Oncol; 2012 Nov; 105(2):241-9. PubMed ID: 23010482
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EGFR antisense treatment of human HNSCC cell lines down-regulates VEGF expression and endothelial cell migration.
    Riedel F; Götte K; Li M; Hörmann K; Grandis JR
    Int J Oncol; 2002 Jul; 21(1):11-6. PubMed ID: 12063543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.